Medtronic Pre-Tax Income 2010-2025 | MDT
Medtronic annual/quarterly pre-tax income history and growth rate from 2010 to 2025. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
- Medtronic pre-tax income for the quarter ending January 31, 2025 was $1.540B, a 4.62% increase year-over-year.
- Medtronic pre-tax income for the twelve months ending January 31, 2025 was $5.223B, a 5.57% decline year-over-year.
- Medtronic annual pre-tax income for 2024 was $4.837B, a 9.82% decline from 2023.
- Medtronic annual pre-tax income for 2023 was $5.364B, a 2.77% decline from 2022.
- Medtronic annual pre-tax income for 2022 was $5.517B, a 41.64% increase from 2021.
| Medtronic Annual Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024 | $4,837 |
| 2023 | $5,364 |
| 2022 | $5,517 |
| 2021 | $3,895 |
| 2020 | $4,055 |
| 2019 | $5,197 |
| 2018 | $5,675 |
| 2017 | $4,602 |
| 2016 | $4,336 |
| 2015 | $3,486 |
| 2014 | $3,705 |
| 2013 | $4,251 |
| 2012 | $4,145 |
| 2011 | $3,664 |
| 2010 | $3,944 |
| 2009 | $2,440 |
| Medtronic Quarterly Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2025-01-31 | $1,540 |
| 2024-10-31 | $1,559 |
| 2024-07-31 | $1,268 |
| 2024-04-30 | $856 |
| 2024-01-31 | $1,472 |
| 2023-10-31 | $1,313 |
| 2023-07-31 | $1,196 |
| 2023-04-30 | $1,550 |
| 2023-01-31 | $1,375 |
| 2022-10-31 | $1,395 |
| 2022-07-31 | $1,044 |
| 2022-04-30 | $1,602 |
| 2022-01-31 | $1,589 |
| 2021-10-31 | $1,493 |
| 2021-07-31 | $833 |
| 2021-04-30 | $1,566 |
| 2021-01-31 | $1,220 |
| 2020-10-31 | $525 |
| 2020-07-31 | $584 |
| 2020-04-30 | $205 |
| 2020-01-31 | $1,579 |
| 2019-10-31 | $1,294 |
| 2019-07-31 | $977 |
| 2019-04-30 | $1,292 |
| 2019-01-31 | $1,370 |
| 2018-10-31 | $1,355 |
| 2018-07-31 | $1,180 |
| 2018-04-30 | $1,725 |
| 2018-01-31 | $1,027 |
| 2017-10-31 | $1,728 |
| 2017-07-31 | $1,195 |
| 2017-04-30 | $1,435 |
| 2017-01-31 | $967 |
| 2016-10-31 | $1,212 |
| 2016-07-31 | $988 |
| 2016-04-30 | $1,134 |
| 2016-01-31 | $1,179 |
| 2015-10-31 | $1,083 |
| 2015-07-31 | $940 |
| 2015-04-30 | $187 |
| 2015-01-31 | $1,194 |
| 2014-10-31 | $1,022 |
| 2014-07-31 | $1,083 |
| 2014-04-30 | $481 |
| 2014-01-31 | $955 |
| 2013-10-31 | $1,116 |
| 2013-07-31 | $1,153 |
| 2013-04-30 | $1,154 |
| 2013-01-31 | $1,155 |
| 2012-10-31 | $854 |
| 2012-07-31 | $1,088 |
| 2012-04-30 | $1,031 |
| 2012-01-31 | $1,053 |
| 2011-10-31 | $1,043 |
| 2011-07-31 | $1,018 |
| 2011-04-30 | $875 |
| 2011-01-31 | $997 |
| 2010-10-31 | $752 |
| 2010-07-31 | $1,040 |
| 2010-04-30 | $1,210 |
| 2010-01-31 | $1,063 |
| 2009-10-31 | $1,110 |
| 2009-07-31 | $561 |
| 2009-04-30 | $9 |
| 2009-01-31 | $893 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $105.579B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.503B | 27.84 |
| Boston Scientific (BSX) | United States | $154.040B | 38.56 |
| Stryker (SYK) | United States | $144.095B | 30.13 |
| EssilorLuxottica (ESLOY) | France | $132.622B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.866B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.124B | 27.36 |
| ResMed (RMD) | United States | $35.477B | 26.65 |
| GE HealthCare Technologies (GEHC) | United States | $30.720B | 14.59 |
| Agilent Technologies (A) | United States | $30.004B | 19.82 |
| Terumo (TRUMY) | Japan | $29.197B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.643B | 16.28 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.255B | 11.72 |
| Insulet (PODD) | United States | $18.215B | 77.74 |
| Baxter (BAX) | United States | $15.352B | 11.47 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.456B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.179B | 17.65 |
| Bio-Rad Laboratories (BIO) | United States | $6.487B | 21.93 |
| Prestige Consumer Healthcare (PBH) | United States | $4.014B | 19.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.368B | 9.64 |
| ICU Medical (ICUI) | United States | $3.306B | 28.16 |
| Haemonetics (HAE) | United States | $3.194B | 15.03 |
| Envista Holdings (NVST) | United States | $2.778B | 23.08 |
| GN Store Nord (GNNDY) | Denmark | $2.069B | 17.14 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.46 |
| QuidelOrtho (QDEL) | United States | $1.750B | 14.65 |
| AtriCure (ATRC) | United States | $1.478B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.281B | 20.17 |
| AdaptHealth (AHCO) | United States | $1.194B | 12.12 |
| Neogen (NEOG) | United States | $1.192B | 15.25 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.043B | 0.00 |
| InMode (INMD) | Israel | $0.995B | 9.11 |
| Phibro Animal Health (PAHC) | United States | $0.771B | 11.83 |
| Evolus (EOLS) | United States | $0.749B | 0.00 |
| Owens & Minor (OMI) | United States | $0.596B | 5.07 |
| Curaleaf Holdings (CURLF) | Canada | $0.579B | 0.00 |
| CeriBell (CBLL) | United States | $0.568B | 0.00 |
| Valneva SE (VALN) | France | $0.542B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.518B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.424B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.420B | 0.00 |
| Surmodics (SRDX) | United States | $0.391B | 0.00 |
| Omeros (OMER) | United States | $0.370B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.340B | 14.75 |
| Capricor Therapeutics (CAPR) | United States | $0.333B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.302B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.292B | 26.43 |
| Sanara MedTech (SMTI) | United States | $0.283B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.259B | 46.10 |
| ZimVie (ZIMV) | United States | $0.245B | 14.65 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.184B | 4.21 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.16 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Brainsway (BWAY) | Israel | $0.162B | 50.65 |
| Organigram Global (OGI) | Canada | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.146B | 17.99 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
| Exagen (XGN) | United States | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.086B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.58 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.061B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 55.50 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 11.14 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |